Here are four notes:
1. LDR has a market cap of $503.95 million.
2. The company’s stock has declined 58.1 percent since July 10, 2015, and it continues to trend down.
3. It has underperformed the S&P500 by 47.9 percent.
4. Out of 10 analysts covering LDR, 11 rate it “buy,” zero “sell,” while one rates it “hold.”
More articles on devices:
43 spine, orthopedic devices receive FDA 510(k) clearance in January
Foot and ankle market to reach $5.4B in 2020 — 4 insights
Wright Medical Group shares receive average price target of $28.11: 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
